« Back to Record
Citation APA

Viale, G., Dell’Orto, P., Glas, A. M., Cardoso, F., Slaets, L., de Snoo, F. F., Bogaerts, J., Russo, L., Van't Veer, L., Rutgers, E. T., Piccart-Gebhart, M., & Stork-Sloots, L. (2016). Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance. Breast cancer research and treatment, 155(3), 463-469. doi:10.1007/s10549-016-3690-6


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231580

Viale, G., Dell’Orto, P., Glas, A. M., Cardoso, F., Slaets, L., de Snoo, F. F., Bogaerts, J., Russo, L., Van't Veer, L., Rutgers, E. T., Piccart-Gebhart, M., & Stork-Sloots, L. (2016). Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance. Breast cancer research and treatment, 155(3), 463-469. doi:10.1007/s10549-016-3690-6